These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9316213)

  • 1. Renal tubular hypertrophy induced by angiotensin II.
    Wolf G; Ziyadeh FN
    Semin Nephrol; 1997 Sep; 17(5):448-54. PubMed ID: 9316213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms.
    Wolf G
    Nephrologie; 1998; 19(7):451-6. PubMed ID: 9857383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective antagonism of the AT1 receptor inhibits the effect of angiotensin II on DNA and protein synthesis of rat proximal tubular cells.
    Weerackody RP; Chatterjee PK; Mistry SK; McLaren J; Hawksworth GM; McLay JS
    Exp Nephrol; 1997; 5(3):253-62. PubMed ID: 9208286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
    Chen J; Chen JK; Neilson EG; Harris RC
    J Am Soc Nephrol; 2006 Jun; 17(6):1615-23. PubMed ID: 16641152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
    Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
    J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II stimulates cellular hypertrophy of LLC-PK1 cells through the AT1 receptor.
    Wolf G; Zahner G; Mondorf U; Schoeppe W; Stahl RA
    Nephrol Dial Transplant; 1993; 8(2):128-33. PubMed ID: 7681154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review.
    Ibrahim HN; Rosenberg ME; Hostetter TH
    Semin Nephrol; 1997 Sep; 17(5):431-40. PubMed ID: 9316211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
    Lijnen P; Petrov V
    J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target?
    Noble NA; Border WA
    Semin Nephrol; 1997 Sep; 17(5):455-66. PubMed ID: 9316214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.
    Kim S; Iwao H
    Pharmacol Rev; 2000 Mar; 52(1):11-34. PubMed ID: 10699153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II down-regulates the SR-BI HDL receptor in proximal tubular cells.
    Wolf G; Wenzel U; Jablonski K; Brundert M; Rinninger F
    Nephrol Dial Transplant; 2005 Jun; 20(6):1222-7. PubMed ID: 15894808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the renin-angiotensin system on the parathyroid hormone-related protein overexpression induced by nephrotoxic acute renal failure in the rat.
    Ortega A; Rámila D; Izquierdo A; González L; Barat A; Gazapo R; Bosch RJ; Esbrit P
    J Am Soc Nephrol; 2005 Apr; 16(4):939-49. PubMed ID: 15728788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiotensin II, endothelin-1, and nitric oxide in HgCl2-induced acute renal failure.
    Yanagisawa H; Nodera M; Umemori Y; Shimoguchi Y; Wada O
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):315-26. PubMed ID: 9853001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist.
    Haddad GE; Blackwell K; Bikhazi A
    Can J Physiol Pharmacol; 2003 Feb; 81(2):142-9. PubMed ID: 12710528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-mediated renal injury.
    Harris RC; Martinez-Maldonado M
    Miner Electrolyte Metab; 1995; 21(4-5):328-35. PubMed ID: 7565481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of a local renin angiotensin system in podocytes by glucose.
    Durvasula RV; Shankland SJ
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of renin-angiotensin system blockade on structure and function of glomerular membrane components in animal models of kidney disease.
    Remuzzi A; Mohamed EI
    Exp Nephrol; 1996; 4 Suppl 1():27-33. PubMed ID: 9001894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.